Oct 29, 2019 / 10:15PM GMT
Operator
Thank you for standing by, and welcome to the ImpediMed quarterly results investor call. (Operator Instructions)
I would now like to hand the conference over to Mr. Rick Carreon, Managing Director and CEO. Please go ahead.
Richard Carreon - ImpediMed Limited - MD, CEO, President & Executive Director
Thank you, Chantel, and welcome, everyone. Thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial year quarter ending 30 September 2019. Our Vice President of Finance, Mr. Tim Cruickshank, will be filling in for Morten Vigeland, our CFO, who is unavailable for today's call.
During our call today, I'll be referencing the 4C we launched earlier this morning in Australian time. As we normally do, I'll take questions following my comments.
This quarter marks a key inflection point for ImpediMed. First of all, Software-as-a-Service became the key revenue and growth generator for the company, and recall, this is a business that is less than 2 years old. Two, we launched the lymphedema
Q1 2020 ImpediMed Ltd Earnings Call Transcript
Oct 30, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers